DATA GRAPHICS | Finance
Tango & Cash: the latest in string of biotech SPAC mergers: Data Byte
Tango, Surrozen bring SPACs this year to 22
April 14, 2021 11:02 PM UTC
Tango and Surrozen completed SPAC deals this week to bring the total number of biotech SPAC mergers to at least 22.
Tango Therapeutics Inc., a synthetic lethality company, said on Wednesday it is merging with BCTG Acquisition Corp. (NASDAQ:BCTG), a SPAC sponsored by Boxer Capital. The deal will give Tango $167 million in BCTG’s IPO proceeds, assuming no future redemptions, plus $186 million through a PIPE from life sciences specialist investors and partner Gilead Sciences Inc. (NASDAQ:GILD). Tango said the capital should provide the company with runway into 2H24...